Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nrc Health (NRC) EPS (Weighted Average and Diluted) (2016 - 2026)

Nrc Health's EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at $49.57 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 17603.57% to $49.57 in Q4 2025 year-over-year; TTM through Dec 2025 was $49.99, a 4660.95% increase, with the full-year FY2025 number at $50.0, up 4707.69% from a year prior.
  • EPS (Weighted Average and Diluted) hit $49.57 in Q4 2025 for Nrc Health, up from $0.18 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for NRC hit a ceiling of $49.57 in Q4 2025 and a floor of -$0.01 in Q2 2025.
  • Historically, EPS (Weighted Average and Diluted) has averaged $2.75 across 5 years, with a median of $0.3 in 2023.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 17603.57% in 2025, down 103.85% in 2025.
  • Tracing NRC's EPS (Weighted Average and Diluted) over 5 years: stood at $0.38 in 2021, then decreased by 28.95% to $0.27 in 2022, then surged by 33.33% to $0.36 in 2023, then fell by 22.22% to $0.28 in 2024, then soared by 17603.57% to $49.57 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for NRC at $49.57 in Q4 2025, $0.18 in Q3 2025, and -$0.01 in Q2 2025.